Biocept (BIOC) Reports Q4 Loss of $0.27

Biocept (NASDAQ: BIOC) reported Q4 EPS of ($0.27), versus ($0.73) reported last year. Revenue for the quarter came in at $1.29 million, versus $218.3 thousand reported last year.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c